Further, Beclin 1 knockdown sensitized GBM cells to TRAIL-induced apoptosis, which was antagonized in the presence of survivin introduction, suggesting that Beclin 1 enhances TRAIL resistance in GBM cells through maintaining the level of survivin [100]. The gene discussed is BIRC5; the disease is glioblastoma.